The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity
Lipid metabolism and receptor-mediated signaling are highly intertwined processes that cooperate to fulfill cellular functions and safeguard cellular homeostasis. Activation of Toll-like receptors (TLRs) leads to a complex cellular response, orchestrating a diverse range of inflammatory events that...
Main Authors: | Leonhard X. Heinz, Christoph L. Baumann, Marielle S. Köberlin, Berend Snijder, Riem Gawish, Guanghou Shui, Omar Sharif, Irene M. Aspalter, André C. Müller, Richard K. Kandasamy, Florian P. Breitwieser, Andreas Pichlmair, Manuela Bruckner, Manuele Rebsamen, Stephan Blüml, Thomas Karonitsch, Astrid Fauster, Jacques Colinge, Keiryn L. Bennett, Sylvia Knapp, Markus R. Wenk, Giulio Superti-Furga |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-06-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124715005045 |
Similar Items
-
A substrate‐based ontology for human solute carriers
by: Eva Meixner, et al.
Published: (2020-07-01) -
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
by: A. Mitrofanova, et al.
Published: (2019-06-01) -
Enhancing cognate target elution efficiency in gel-free chemical proteomics
by: Branka Radic-Sarikas, et al.
Published: (2015-12-01) -
SMPDL3B Predicts Poor Prognosis and Contributes to Development of Acute Myeloid Leukemia
by: Huiqing Qu, et al.
Published: (2021-08-01) -
Introduction to computational proteomics.
by: Jacques Colinge, et al.
Published: (2007-07-01)